IQVIA™ Real-World Insights Bibliography

The impact of the new innovative algorithm in Italy
Author(s): Rova A1, Cioni L1, Urbinati D1
Affiliations(s): 1 IQVIA, RWI, Milan, Italy
Publication(s):  ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain
Document Type(s): Poster,
Countries: Italy,
C:
Y:
Health policy, Public Health, Regulatory,
2018
  L:
A:
English
  Add to report
 
 
The evolution of standard monitoring registries in the Italian market
Author(s): Cioni L1, Rova A1, Urbinati D1
Affiliations(s): 1 IQVIA, RWI, Milan, Italy
Publication(s):  ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain
Document Type(s): Poster,
Countries: Italy,
C:
Y:
Health policy, Public Health, Regulatory,
2018
  L:
A:
English
  Add to report
 
 
Off-Label Prescription of Drugs Compared to Prescription After Label Extension in Children for Germany
Author(s): Gohlke A, Kostev K, Kuschel AS
Affiliations(s): IQVIA Commercial GmbH & Co. OHG, Munich, Germany
Publication(s): 
Document Type(s): 
Countries: 
C:
Y:
Health policy, Pediatrics, Regulatory,
2018
  L:
A:
English
Utility analysis,
  Add to report
 
 
The impact of managed entry agreements on drug time to market in Italy
Author(s): Mantuano M1, Rova A1, Urbinati D1
Affiliations(s): 1 QuintilesIMS, Milan, Italy
Publication(s):  ISPOR 20th Annual European Congress, 4-8 November 2017, Glasgow, Scotland
Document Type(s): Poster,
Countries: Italy,
C:
Y:
Health policy, Regulatory,
2017
  L:
A:
English
Literature Review,
  Add to report
 
 
The impact of biosimilar launch on molecule price and pharmaceutical expense: the case of the insulin glargine in Italy
Author(s): Tucci C1, Cioni L1, Mantuano M1, Tettamanti A1
Affiliations(s): 1 QuintilesIMS, Milan, Italy
Publication(s):  ISPOR 20th Annual European Congress, 4-8 November 2017, Glasgow, Scotland
Document Type(s): Poster,
Countries: Italy,
C:
Y:
Diabetes, Health policy, Pricing and reimbursement, Regulatory,
2017
  L:
A:
English
Literature Review, Pricing & Reimbursement, Public Health,
  Add to report
 
 
Drug commercialization before the pricing and reimbursement in Italy: the non negotiated C Class (C-nn)
Author(s): Mantuano M1, Cioni L1
Affiliations(s): 1 QuintilesIMS, Milan, Italy
Publication(s):  ISPOR 20th Annual European Congress, 4-8 November 2017, Glasgow, Scotland
Document Type(s): Poster,
Countries: Italy,
C:
Y:
Health policy, Pricing and reimbursement, Regulatory,
2017
  L:
A:
English
Literature Review, Pricing & Reimbursement, Public Health,
  Add to report
 
 
Centralization and complexity of drug market access process across Italian regions
Author(s): Tucci C1, Cioni L1, Mantuano M1, Urbinati D1
Affiliations(s): QuintilesIMS, Milan, Italy
Publication(s):  ISPOR 20th Annual European Congress, 4-8 November 2017, Glasgow, Scotland
Document Type(s): Poster,
Countries: Italy,
C:
Y:
Health policy, Public Health, Regulatory,
2017
  L:
A:
English
Literature Review, Public Health, Survey research,
  Add to report
 
 
Regional market access pathways for diagnostics in Italy.
Author(s): Mantuano M1, Dionisi M2, Paolini D2, Gancitano G2, Urbinati D1
Affiliations(s): 1 IMS Health, Milan, Italy 2 Roche Diagnostics, Italy.
Publication(s):  ISPOR 19th Annual European Congress, 2016, 29 October-2 November, Vienna, Austria.
Document Type(s): Poster,
Countries: Italy,
C:
Y:
Health policy, Pricing and reimbursement, Regulatory,
2016
  L:
A:
English
Review,
  Add to report
 
 
Prevention of venous thromboembolic events by fondaparinux 2.5mg in general practice. ArchiMed Ville
Author(s): Mahé I1, Daurès JP2, Pouchain D3, Quéré I4, Aubin C5, Doussaint J6, Schück S6, Leroyer C7
Affiliations(s): 1EA 7334 méthodologies et société (REMES), hôpital Louis-Mourier, université Paris 7, AP-HP, 178, rue des Renouillers, 92700 Colombes, France. 2IURC de Montpellier, 641, avenue du Doyen-Gaston-Giraud, 34093 Montpellier cedex, France; CHU de Nîmes, 30029 Nîmes, France. 3Département de médecine générale, UFR Tours, 10, boulevard Tonnellé, BP 3223, 37032 Tours cedex 1, France. 4Hôpital Saint-Eloi, CHRU de Montpellier, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France. 5Laboratoire GlaxoSmithKline, 100, route de Versailles, 78160 Marly-le-roi, France. 6Kappa Santé, 4, rue de Cléry, 75002 Paris, France. 7Département de médecine interne et de pneumologie, université européenne de Bretagne, CHU de la Cavale-Blanche, boulevard Tanguy-Prigent, 29609 Brest cedex, France
Publication(s):  J Mal Vasc. 2015 Jul 20. pii: S0398-0499(15)00121-3
Document Type(s): Article,
Countries: France,
C:
Y:
Cardiovascular disease, Drug Utlization Study, Orthopedics, Regulatory, Vascular disease,
2015
  L:
A:
English
Prospective study,
  Add to report
 
 
Understanding patterns of monitoring of appropriate prescribing in Europe
Author(s): Schroeder C1, Keja J2, Toussi M3, Hughes B2
Affiliations(s): 1 IMS Health, Munich, Germany 2 IMS Health, London, UK 3 IMS Health, Paris, France
Publication(s):  ISPOR 16th annual european congress, 2013, November 2-6, Dublin, Ireland
Document Type(s): Poster,
Countries: Europe,
C:
Y:
Health policy, Regulatory,
2013
  L:
A:
English
Review,
  Add to report
 
 
 1 of 2 Next Page Last Page